Summary
IDEXX Laboratories, Inc. reported strong financial results for the six months ended June 30, 2011, demonstrating robust revenue growth across its key segments, particularly in Companion Animal Group (CAG) and Livestock and Poultry Diagnostics (LPD). Total revenue increased by 11.0% year-over-year to $610.5 million, driven by organic growth of 7.9% and a favorable currency impact of 3.1%. The company saw improved profitability with gross profit increasing by 12.8% to $328.9 million and operating income rising by 20.9% to $124.8 million. Financially, IDEXX maintained a healthy liquidity position with $159.4 million in cash and cash equivalents and $195.4 million in working capital at the end of the period. The company actively managed its capital structure, utilizing operating cash flows and a revolving credit facility, while also continuing its share repurchase program. Despite facing some headwinds from economic conditions and ongoing regulatory investigations in the US and UK, IDEXX's diversified business model and strategic focus on innovation appear to be driving continued growth and operational efficiency.
Financial Highlights
50 data points| Revenue | $317.86M |
| Cost of Revenue | $143.83M |
| Gross Profit | $174.03M |
| R&D Expenses | $18.62M |
| Operating Income | $71.30M |
| Interest Expense | $782K |
| Net Income | $48.66M |
| EPS (Basic) | $0.42 |
| EPS (Diluted) | $0.41 |
| Shares Outstanding (Basic) | 114.55M |
| Shares Outstanding (Diluted) | 117.45M |
Key Highlights
- 1Total revenue for the first six months of 2011 increased 11.0% to $610.5 million, with organic revenue growth of 7.9%.
- 2Operating income for the first six months of 2011 grew by 20.9% to $124.8 million, indicating improved operational efficiency.
- 3The Companion Animal Group (CAG) remains the largest segment, with revenue up 10.3% to $500.3 million, driven by instruments, consumables, and reference laboratory services.
- 4Livestock and Poultry Diagnostics (LPD) showed significant growth, with revenue increasing 26.1% to $49.3 million, bolstered by increased sales of bovine and swine tests.
- 5The company maintained strong liquidity, with cash and cash equivalents of $159.4 million and $66.5 million in remaining borrowing availability under its credit facility as of June 30, 2011.
- 6IDEXX repurchased $98.4 million of its common stock during the first six months of 2011 as part of its ongoing share repurchase program.
- 7The company noted ongoing investigations by the U.S. Federal Trade Commission (FTC) and the UK Office of Fair Fair Trading (OFT) related to marketing and sales practices, though it believes its practices are compliant.